Buy or sell Curebase stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Curebase Stock

Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.

Founded

2017

Notable Investors

Bold Capital Partners

Headquarters

San Francisco CA, US

Total Funding

$17.6M

About Curebase Stock

Curebase builds a digital clinical trial assistant that would alter how medical providers discover, activate, and administer clinical trials for their patients. It aims to run clinical trials faster and cheaper than anyone else via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. The company was established in 2017 and is based in San Francisco, California.

Investors

Funding History

August 2018$120K
October 2018$2.5M
May 2021$15.0M

Management

Founder & CEO

Tom Lemberg

CTO

Matthew Rials

Investor

Jeff Richards

Vice President Of Business Development

Wayne Bowden

Chief Operating Officer

Storm Stillman

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo